CLINICAL_TRIALS
trial_result
· 2023-10-17
Clinical Trial Update: A Study of Isatuximab-based Therapy in Participants With Lymphoma [Phase 1, Phase 2]
Summary
A Phase 1/2 study of isatuximab-based therapy for lymphoma was terminated, with results posted in October 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-10-17